Publication: Chemopreventive efficacy of stampidine in a murine breast cancer model
Loading...
Date
2020-02-07T00:00:00Z
Authors
Authors
Sahin, Kazim
Orhan, Cemal
Ozercan, Ibrahim Hanifi
Tuzcu, Mehmet
ELİBOL, BİRSEN
ŞAHİN, TAHA KORAY
Kilic, Ulkan
Qazi, Sanjive
Uckun, Fatih Mehmet
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Background: The purpose of the present study was to examine the chemopreventive effect of stampidine, an aryl phosphate derivative of stavudine, in side by side comparison with the standard anti-breast cancer drug paclitaxel in the well-established 7,12-dimethylbenz(a)anthracene (DMBA)-induced murine breast cancer model. Methods: Groups of 20 female mice were challenged with the DMBA. DMBA-challenged mice were assigned to various chemoprevention treatments, including stampidine, paclitaxel, and stampidine plus paclitaxel according to the same treatment schedules for 25 weeks. Results: Stampidine resulted in substantially reduced numbers of tumors, tumor weight as well as tumor size in DMBA-treated mice. Stampidine was as effective as paclitaxel in the model and their combination exhibited greater chemopreventive activity, as measured by reduced tumor incidence and improved tumor-free survival as well as overall survival of DMBA-treated mice. The length of time for the initial tumor to appear in DMBA-challenged mice treated with stampidine was longer than that of mice treated DMBA-challenged control mice. Tumors from mice treated with stampidine or stampidine plus paclitaxel displayed unique changes of a signature protein cassette comprised BRCA1, p21, Bax, and Bcl-2. Conclusion: Stampidine has potent chemopreventive activity and is as effective as the standard chemotherapy drug paclitaxel in the chemical carcinogenesis.
Description
Keywords
stampidine, cancer
Citation
Sahin K., Orhan C., Ozercan I. H. , Tuzcu M., ELİBOL B., ŞAHİN T. K. , Kilic U., Qazi S., Uckun F. M. , -Chemopreventive efficacy of stampidine in a murine breast cancer model-, EXPERT OPINION ON THERAPEUTIC TARGETS, cilt.24, ss.155-162, 2020